Prescription drug · ANDA
Progesterone NDC 69452-233
Progesterone 100 mg/1 · Capsule · Oral · Bionpharma Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 69452-233-20 | 6945202332069452023320 | 100 CAPSULE in 1 BOTTLE (69452-233-20)Marketed from Nov 28, 2018 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Progesterone
- Generic name (nonproprietary)
- progesterone
- Active ingredients
- Progesterone — 100 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Bionpharma Inc.NDC labeler code 69452
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 200900
- Marketing start
- Listing expires
- Other FDA classes
- Progesterone (Chemical structure)
- Identifiers
- Product ID 69452-233_52f7a501-4d23-0fbc-e063-6394a90a4b94SPL ID 52f7a501-4d23-0fbc-e063-6394a90a4b94SPL set ID 41b3c3a7-5fb8-4451-a96c-2bd02613c021RxCUI 260243, 312641UNII 4G7DS2Q64YUPC 0369452234204, 0369452233207
- Pharmacologic class
- Progesterone
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N469452023320followed by a unit qualifier and the quantityPackage 69452-0233-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Progesterone capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. They are also indicated for use in secondary amenorrhea.
Excerpt only. Read the full label for complete information.
About NDC 69452-233
- What is NDC 69452-233?
- 69452-233 is the product NDC for Progesterone, Progesterone 100 mg/1 capsule, listed with the FDA by Bionpharma Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Progesterone.
- What is the active ingredient?
- Progesterone.
- Who is the labeler?
- Bionpharma Inc., NDC labeler code 69452. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Progesterone?
- 73 other product NDCs are listed under this name. See all Progesterone NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Progesterone products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | NorthStar Rx LLC | 72603-974 | 72603-0974-01 |
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | NorthStar Rx LLC | 72603-975 | 72603-0975-01 |
| Progesterone | Progesterone 100 mg/1 | InsertVaginal | Sun Pharmaceutical Industries, Inc. | 70095-136 | 70095-0136-03 |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | Preferred Pharmaceuticals Inc. | 68788-4068 | 68788-4068-03 |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | REMEDYREPACK INC. | 70518-4552 | 70518-4552-00 |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | Direct_Rx | 72189-654 | 72189-0654-90 |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | AvKARE | 73190-064 | 73190-0064-01 |
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | AvKARE | 73190-065 | 73190-0065-01 |
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | Preferred Pharmaceuticals Inc. | 68788-4015 | 68788-4015-03 |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | Hikma Pharmaceuticals USA Inc | 0054-0829 | 00054-0829-25 |
Other NDCs under ANDA 200900
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | A-S Medication Solutions | 50090-6771 |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | Golden State Medical Supply, Inc. | 51407-980 |
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | Golden State Medical Supply, Inc. | 51407-981 |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | Bryant Ranch Prepack | 71335-9739 |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | Bionpharma Inc. | 69452-148 |
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | Bionpharma Inc. | 69452-149 |
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | Bionpharma Inc. | 69452-234 |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | Preferred Pharmaceuticals Inc. | 68788-8709 |
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | NuCare Pharmaceuticals,Inc. | 68071-3529 |
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | Preferred Pharmaceuticals Inc. | 68788-8719 |
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | Bryant Ranch Prepack | 71335-2242 |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | NuCare Pharmaceuticals,Inc. | 68071-3557 |
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | Proficient Rx LP | 82804-268 |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | REMEDYREPACK INC. | 70518-4166 |
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | Asclemed USA, Inc. | 76420-580 |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | Asclemed USA, Inc. | 76420-582 |